Health Care & Life Sciences » Pharmaceuticals | Premier Biomedical Inc.

Premier Biomedical Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
-
-
-
-
39.80
39.80
Cost of Goods Sold (COGS) incl. D&A
0.80
1.00
1.50
2.10
25.40
113.70
Gross Income
0.80
1.00
1.50
2.10
14.30
73.90
SG&A Expense
4,476.00
1,368.00
2,381.80
635.80
1,304.20
618.90
EBIT
4,476.70
1,368.90
-
637.90
1,289.80
692.80
Unusual Expense
-
-
20.10
312.90
2,116.00
709.20
Interest Expense
400.40
41.60
198.00
817.40
351.50
415.30
Pretax Income
4,877.10
1,410.50
2,601.40
1,768.20
3,763.60
398.90
Consolidated Net Income
4,877.10
1,410.50
2,601.40
1,768.20
3,763.60
398.90
Net Income
4,877.10
1,410.50
2,601.40
1,768.20
3,763.60
398.90
Net Income After Extraordinaries
4,877.10
1,410.50
2,601.40
1,768.20
3,763.60
398.90
Net Income Available to Common
4,957.10
1,410.50
2,601.40
1,768.20
3,763.60
398.90
EPS (Basic)
78.29
17.28
20.00
2.50
2.50
0.11
Basic Shares Outstanding
63.30
81.60
125.10
606.60
1,958.70
3,505.50
EPS (Diluted)
78.29
17.28
20.80
2.91
1.92
0.11
Diluted Shares Outstanding
63.30
81.60
125.10
606.60
1,958.70
3,505.50
EBITDA
4,476.00
1,368.00
2,381.80
635.80
1,287.50
690.50
Equity in Affiliates (Pretax)
-
-
-
-
6.20
-
Preferred Dividends
79.90
-
-
-
-
-

About Premier Biomedical

View Profile
Address
PO Box 25
Jackson Center Pennsylvania 16133
United States
Employees -
Website http://www.premierbiomedical.com
Updated 07/08/2019
Premier Biomedical, Inc. is a research-based company, which engages in the development and marketing of medications and procedures. It intends to discover and develop medical treatments for humans, specifically targeting the treatment of alzheimer's disease, fibromyalgia, multiple sclerosis, traumatic brain injury, amyotrophic lateral sclerosis, blood sepsis and viremia, and cancer. The company was founded by Mitchell S.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.